Exposants de ICASA 2023

Abbott is a global leader in in vitro diagnostics with one of the broadest portfolios of businesses spanning nearly every segment – point of care, immunoassay, clinical chemistry, hematology, blood screening, molecular, and informatics. Abbott’s life-changing tests and diagnostic tools provide accurate, timely information to better manage health. We’re empowering smarter medical and economic decision making to help transform the way people manage their health at all stages of life.

AccuBio are a UK-based in vitro diagnostics company focussed on delivering rapid, cost-effective diagnostic solutions to expedite clinical management, improve patient outcomes and promote equitable access to healthcare for everyone.In addition to our comprehensive infectious disease and drugs of abuse lateral flow test portfolio for either self-testing or use in near-patient settings AccuBio’s VISITECT® CD4 Advanced Disease test, the world’s first rapid, instrument-free, semi-quantitative lateral flow test, supports same day identification of advanced disease in people living with HIV.

The AIDS and Rights Alliance for Southern Africa (ARASA) was founded in 2003 and works with 115 partners within 18 countries in East and Southern Africa aiming to amplify voices regarding Health Financing, HIV/TB prevention and Sexual Reproductive Health and Rights for marginalised groups in their diversities as women, adolescent girls, people on the move, people who use drugs, and key populations through a human rights-based approach. ARASA’s 2023-2028 Strategy is centred on Increased Capacity, Coordination and Accountability (ICCA) for Equality and dovetails with developmental megatrends which include climate change, digital divide and migration and their intersectionality human rights.

Avacare is a leading healthcare organization dedicated to improving access to quality healthcare services in Africa. With a strong focus on innovation, Avacare aims to create sustainable healthcare solutions that address the unique challenges faced by the African population and beyond. Established in 1996, Avacare Health has developed a significant footprint across Africa, emerging as a prominent player in the healthcare industry. With a formidable presence in 22 countries, the company has grown exponentially, boasting a workforce of 1500 employees dedicated to delivering quality healthcare solutions. Avacare Health’s extensive network includes 47 sales offices, 15 manufacturing sites, and 25 warehouses, strategically positioned to efficiently serve the continent's diverse healthcare needs. With a product portfolio of over 2500 healthcare solutions, the company caters to a vast array of medical requirements, touching the lives of over 600 million people in Africa. Notably, the establishment of Afrigen, the mRNA Hub in Cape Town and FARMOVS, a cutting-edge clinical research facility further highlights Avacare Health's commitment to innovation and advancing medical breakthroughs, solidifying its influential impact on healthcare throughout the region.

Aurobindo Pharma’s mission is to provide wide range of high-quality ARVs (USFDA Approved) for PLHIV & CLHIV with high accessibility to over 125 countries. Aurobindo Pharma is a knowledge driven company with strong R&D infrastructure to develop generic versions of state-of-the-art latest molecules. Our R&D capabilities includes both active pharmaceutical ingredients (APIs) and finished dose formulations (FDFs), thus being a reliable vertically integrated company for assuring uninterrupted global supplies. Our ARV journey started more than 2 decades ago and have been consistently participating in global HIV programmes. Aurobindo Pharma has filed more than 38 ANDAs so far with USFDA. Aurobindo Pharma has developed range of products and have several other molecules in pipeline. eg. Tenofovir alafenamide, Cabotegravir long-acting injectable/tablet, Paediatric Abacavir/Lamivudine/Dolutegravir etc., Aurobindo Pharma’s commitment to paediatric HIV is demonstrated through uninterrupted supplies of products like Abacavir, Nevirapine & Zidovudine to selected markets, where it is still being used for PMTCT and other therapies.

BIOCENTRIC and the BRUKER Group offer complete solutions in microbiology and diagnostics: in vitro diagnostic reagents, instrumentation, training, maintenance; with applications in virology, bacteriology, mycobacteriology, mycology and human genetics.

For over 20 years, BIOCENTRIC has been Africa's partner in the fight against AIDS and viral hepatitis, as well as chronic and emerging infectious diseases.

BIOCENTRIC collaborates actively with National HIV Programs, NGOs, Reference Centers and Ministries of Health to support healthcare professionals in patient management. BIOCENTRIC et le groupe BRUKER proposent des solutions complètes en microbiologie et diagnostic : réactifs de diagnostic in vitro, instrumentation, formation, maintenance ; avec des applications en virologie, bactériologie, mycobactériologie, mycologie et génétique humaine.

Depuis plus de 20 ans, BIOCENTRIC est le partenaire de l’Afrique dans la lutte contre le SIDA et les Hépatites virales et contre les maladies infectieuses chroniques et émergentes.

BIOCENTRIC collabore activement avec les Programmes Nationaux de Lutte contre le VIH, les ONG, les Centres de Référence, les Ministères de la Santé pour accompagner les professionnels de santé dans la prise en charge des patients.

bioLytical empowers clinicians and the public to make informed health decisions, faster. Combining made-in-Canada quality with a global focus, bioLytical is a leader in the field of rapid in vitro medical diagnostics.

Its range of one-minute INSTI® tests provide instant, accurate results for infectious diseases including COVID-19, HIV, Hepatitis C (HCV) and Syphilis among others.

Cepheid's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, Tuberculosis and emerging infectious diseases, healthcare-associated infectious diseases, oncology, and human genetics. The company's solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. We call this the PCRplus advantage.

Chemonics International Inc. is a development firm with more than 40 years of experience working in more than 150 countries. Chemonics is a trusted implementing partner that is committed to solving the world’s toughest development challenges with multidisciplinary teams working across sectors. Most notably, Chemonics and partners lead the implementation of the USAID Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project. GHSC-PSM has offices in 35 countries and collaborates with ministries of health (MOHs) to advance and sustain efficient and resilient health supply chains, thereby increasing access to lifesaving health commodities to the people who need it most.

The Children’s Investment Fund Foundation (CIFF) is one of the world’s largest independent funders of children, with offices in Addis Ababa, Beijing, London, Nairobi, and New Delhi.

Established in 2002, CIFF’s mission is to create a world where every child can live a healthy, fair and safe life. With a rigorous and evidence-driven mindset, CIFF supports bold interventions that focus on making systemic change. This includes programmes on child health, sexual and reproductive health and rights, opportunities for girls and young women, as well as tackling the climate emergency.

The Civil Society Institute for Health in West and Central Africa, comprising of over 150 NGOs and CSOs, is a first of its kinds regional mechanism launched in 2019 to develop an effective and sustainable health response in both sub-regions. Operating in 21 countries, its objectives include developing capacity, coordinating and harmonizing actions of civil society organizations in the health sector, with a focus on promoting inclusive financing mechanisms, strengthening civil society to influence health policies, and optimizing resources. In 2024, the CSIH-WCA’s key priorities revolve around political engagement, addressing pediatric HIV, ensuring fair remuneration for healthcare workers, and providing ongoing support to CSOs through Community-led Monitoring.

Créé par décret en 2017 et actualisé en 2023 (décret N°2023-079 du 15 mars 2023), le Conseil National de Lutte contre le VIH/Sida, la Tuberculose, le Paludisme, les Hépatites, les Infections Sexuellement Transmissibles et les Epidémies (CNLS-TP) est l'instance de veille, d'orientation et de coordination en matière de riposte à ces maladies cibles ainsi que de coordination de l’approche « One Health » au Bénin. Il est présidé par le Ministre de la Santé. Son organe délibérant comprend un Représentant du Président de la République, une quinzaine de ministres, préfets, partenaires, société civile et représentants de populations cibles, des cadres. Il dispose d’un Secrétariat Exécutif, de programmes sectoriels dans les ministères, de démembrements dans les 12 départements et 77communes du pays.

Coalition PLUS est une union internationale d’associations communautaires de lutte contre le VIH/sida et les hépatites virales créée en 2008, intervenant dans 52 pays et auprès d’une centaine d’organisations de la société civile. Nos associations membres et partenaires impliquent les communautés les plus vulnérables au VIH/sida et aux hépatites dans la définition et la mise en œuvre de programmes de prévention, de soins et de plaidoyer. Elles font la promotion de méthodes innovantes, adaptées aux personnes les plus discriminées dans l’accès à la santé. Nos valeurs : solidarité, respect de la diversité et du non-jugement, innovation.

The Drugs for Neglected Diseases initiative (DNDi) is a not-for-profit medical research organization that discovers, develops, and delivers safe, effective, and affordable treatments for neglected people. DNDi is developing medicines for sleeping sickness, leishmaniasis, Chagas disease, river blindness, mycetoma, dengue, paediatric HIV, advanced HIV disease, cryptococcal meningitis, and hepatitis C. Its research priorities include children’s health, gender equity and gender-responsive R&D, and diseases impacted by climate change. Since its creation in 2003, DNDi has joined with public and private partners across the globe to deliver twelve new treatments, saving millions of lives. dndi.org

• The Cospharm group of companies has physical presence in Botswana, Namibia, Zimbabwe, South Africa, and has remote operations in Zambia.
• The Group sells, markets, distributes and manufactures healthcare products throughout these countries.
• The business now has 19 outlets in Namibia, Botswana, Zimbabwe, and South Africa.
• More than 400 products have been registered in more than 4 countries and new products are under registration with various regulatory authorities in Southern Africa.
• In 2021 Cospharm Zimbabwe ventured into generic pharmaceutical development and was licensed to manufacture.
• Our goal is to be a fully integrated generic pharmaceutical company.
• The growth success of the company is attributed in part to highly qualified personnel with a clear pharmaceutical market understanding and in part to its practice of partnering the best manufacturers globally.
• Cospharm endeavours to be better always. In every area of society, the company invests in projects that promote better standards for all. This is because we "Believe in Good".

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a proven leader in the global fight to end HIV and AIDS, and an advocate for children to live full and healthy lives into adulthood. Founded more than 30 years ago through a mother’s determination, EGPAF is committed to a comprehensive response to fighting HIV and AIDS through research, global advocacy, strengthening of local health care systems, and growing the capacity of governments and communities in the world’s most affected regions to respond to urgent needs. Each stage of life brings new and different challenges, and EGPAF is driven to see a world where no other mother, child, or family is devastated by this disease.

Family AIDS Caring Trust Zimbabwe (FACT Zimbabwe) is a Christian based organisation that was instituted in 1987 as Zimbabwe’s first AIDS Service Organisation pioneering the HIV response in Zimbabwe.

36 years down the line since establishment, FACT Zimbabwe continues to compliment Government of Zimbabwe’s efforts in responding to HIV and AIDS through direct services to local communities. FACT Zimbabwe through partnerships has contributed immensely to the national, regional, and international responses to HIV and AIDS and continue to play a pivotal role in building capacities of Community Based Organisations (CBOs) in Zimbabwe and regionally.

Launched in 2011, L’Initiative is a French facility that complements the Global Fund against AIDS, tuberculosis and malaria. It provides technical assistance and support to catalytic projects in around 40 to Global Fund recipient countries to improve the effectiveness of grants and strengthen the health impact of the programs funded.

L’Initiative’s recent evolution has demonstrated its catalytic effect through building the capacity of health stakeholders, improving institutional, political and social frameworks, supporting innovative approaches to respond to pandemics and strengthening systems for health.

Implemented by Expertise France, it is fully funded by the French Ministry for Europe and Foreign Affairs.

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine.

Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives.

The Female Health Company (FHC) was founded in the 1980s during the AIDS epidemic as a socially responsible enterprise to develop and pioneer the use of the world’s first female condom, providing female initiated dual protection against both sexually transmitted infections, such as HIV, as well as unplanned pregnancy.

FHC continues to support and facilitate public-private partnerships around the world, working with governments, civil society representatives and the private sector to empower women through an integrated approach to sexual health and wellness. Since our foundation, we have been distributed in 150 countries around the world.

Throughout our 25 years of experience, we have continued to provide to African countries with the necessary educational and technical support to both raise the awareness of the female condom and to provide greater choice to people as part of a well-trained network of health service providers, community agents and peer educators.

Genesis Analytics is a global African firm that has worked in more than 95 countries across the world. Our roots are firmly in Africa, with offices in South Africa, Kenya, Nigeria, Ethiopia, and Côte d’Ivoire. As a firm, we work across sectors, including Health, WASH, nutrition, education, climate finance, women’s economic empowerment, digital, and others.

Within the Genesis Health Practice, we work with our clients to develop solutions aimed at improving the health of populations throughout Africa. Our areas of expertise are in research, monitoring and evaluation, health financing and economics, and programme implementation support.

Visit our website to find out more: genesis-analytics.com

Global Black Gay Men Connect (GBGMC) is an international advocacy and networking organization committed to improving the health, well-being, and rights of black gay men globally, GBGMC aims to address the unique challenges faced by gay men in the region, particularly related to HIV prevention, treatment, and rights. This International AIDS Conference in Harare, Zimbabwe, presents a vital opportunity for GBGMC to engage, share expertise, and collaborate with stakeholders from around the world.

Grassroot Soccer (GRS) is an adolescent health organization that leverages the power of soccer to equip young people with the life-saving information, services, and mentorship they need to live healthier lives. Since 2002, GRS has reached over 18 million adolescents and youth globally and brings expertise in adolescent social and behavior change, sexual and reproductive health and rights, HIV prevention and adherence support, violence prevention, mental health, and positive youth development.

Guangzhou Wondfo Biotech Co., Ltd., founded in 1992, a company with 3,000+ employees worldwide, has been focusing on the R&D, production, sales and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic disease management solutions for 30 years. Building upon the solid research level and technological innovation capabilities, Wondfo has multiple products for the rapid identification of cardiovascular diseases, inflammation, tumor, infectious diseases, drug abuse, pregnancy etc. widely provided to 140+ countries and regions.

Hetero is one of the world’s leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with a strong footprint in 145+ countries. Backed by 30 years of presence, 38 state-of-the-art manufacturing facilities and a dedicated workforce of 25,000+ mployees, we are serving the world by moulding science and technology into high-quality therapies.

With unparalleled strengths in pharmaceutical research, manufacturing and marketing, we are continually expanding our reach and capabilities to meet the ever-evolving healthcare needs at affordable costs. Catering to 40% of the existing global demand for Anti-Retroviral (ARV) APIs and Finished Dosage Forms (FDFs) critical for HIV/AIDS treatment, remains an illustrious hallmark of our legacy.

Hologic is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. We deliver life-changing and life-saving detection, diagnostic and surgical innovations that are rooted in science, driven by technology and inspired by a desire to improve the health of women and families around the world.

While we focus on women’s health and well-being, we are committed to having an even broader benefit for the world. Together, we advocate for better health and wellness through solutions that provide ever greater certainty and peace of mind.

HUMANA People to People (HUMANA) is an international network of 29 local NGOs working for the sustainable development of vulnerable communities, particularly from Sub-Saharan Africa, Europe, the Americas, and Asia. In our unwavering commitment to tackling some of the world’s major health, socioeconomic, environmental, and humanitarian challenges, we spearhead community-driven holistic development programmes that harness the power of education and collaboration. Moreover, our teams are comprised by people hailing from the very communities we serve, offering invaluable local insights and expertise.

The HIV Vaccine Trials Network (HVTN) is an international collaboration of scientists, clinical trial sites, and community representatives working with governments and industry in the global search for an HIV vaccine with the goal of speeding the development and evaluation of HIV vaccine candidates. The HVTN is the world’s largest publicly funded clinical trials program dedicated to finding an effective HIV vaccine. The HVTN helps advance the fields of vaccinology, social and behavioral sciences, statistics, and immunology, as well as tuberculosis and COVID-19 vaccines.

The HIV Vaccine Trials Network (HVTN) is an international collaboration of scientists, clinical trial sites, and community representatives working with governments and industry in the global search for an HIV vaccine with the goal of speeding the development and evaluation of HIV vaccine candidates. The HVTN is the world’s largest publicly funded clinical trials program dedicated to finding an effective HIV vaccine. The HVTN helps advance the fields of vaccinology, social and behavioral sciences, statistics, and immunology, as well as tuberculosis and COVID-19 vaccines.

IAS – the International AIDS Society – convenes, educates and advocates for a world in which HIV no longer presents a threat to public health and individual well-being. After the emergence of HIV and AIDS, concerned scientists created the IAS to bring together experts from across the world and disciplines to promote a concerted HIV response. Today, the IAS and its members unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all those living with and affected by HIV. The IAS also hosts the world’s most prestigious HIV conferences: the International AIDS Conference, the IAS Conference on HIV Science and the HIV Research for Prevention Conference.

IMMY focuses primarily on bringing rapid, high-quality fungal diagnostics closer to the patient. We have a long history of delivering accurate and affordable solutions that can be implemented in any laboratory setting, on any shift, around the world. IMMY is bridging the gap between fungal infections and proper treatment through rapid diagnostics for Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, and Blastomycosis.

InTec is a world leading manufacturer in infectious disease diagnostics focusing on screening at the Point of Care. In past 34 years we have focused on rapid diagnostics for infectious diseases and other tests for low resourced settings. InTec has a good reputation globally for quality and performance. We have focused on quality products and ensure all certifications are in place. InTec obtained the WHO Pre-Qualification for HIV and HCV rapid tests in 2019, and continually supports NGOs globally. We are a global leader in HIV and Hepatitis screening, and are dedicated to the continued development of innovative testing.

The IPM South Africa, an affiliate of the Population Council is a nonprofit organization which works to develop HIV prevention products and other sexual and reproductive health technologies for women, and to make them available and accessible where they are urgently needed.

A Johns Hopkins University affiliate, Jhpiego is a nonprofit global leader in the creation and delivery of transformative health care solutions that save lives. Through our close partnerships with local communities, policymakers, donors and health providers, we are able to transform health care systems, leading to better health across a lifespan—from pregnancy to delivery, and beyond. By embedding our know-how and skills into everyday practice, we are creating lasting change that improves the health of some of the world’s most disadvantaged for generations to come.

JSI is public health care and health systems consultants and researchers driven by a passion to improve health services and outcomes for all. Our fundamental goal is to ensure that all individuals can live their best and healthiest life.

In pursuit of our goal, we provide innovative management consulting and technical assistance incorporating a broad range of skills. Founded in 1978, we collaborate with government agencies, the private sector, and local nonprofit and civil society organizations to identify and implement solutions to public health challenges. These partnerships improve the quality, accessibility, and equity of health systems and lead to better health outcomes.

With more than 3 decades of manufacturing experience in the healthcare industry, Karex is known as the World's Largest Condom Manufacturer with the ability to produce more than 5 billion pieces of condoms annually. Its other offerings include Personal Lubricants, Probe Covers, Foley Balloon Catheters, Nitrile Gloves & Oral Dams. Along with 3,500 employees and four advanced manufacturing facilities in Malaysia and Thailand, Karex conforms to major international standards and holds various global certifications enabling exports to more than 140 countries. Karex sales and distribution channels are also supported by offices in the UK, USA, Thailand, and Malaysia.

Laurus Labs is a leading generic pharmaceutical company in India. In the late 2000s, Noting the lack of affordable ARV treatments for the PLHIVs in the developing world, we embarked on a journey to expand ART access through sustained R&D efforts for process improvements of key ARV molecules like Efavirenz and Tenofovir along with continuous investments in establishing dedicated manufacturing facilities enabling multi-ton production equivalent to supporting the needs of 6 mn PLHIVs across the globe. Today, Laurus Labs caters to customers of more than 100 countries across the globe with one in three PLHIVs relying on a Laurus Labs product either directly or indirectly. Laurus Labs is also foraying into pediatric ARV treatment with innovative formulations to expand access for the underserved CLHIV population.

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, MPP has signed agreements with 20 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, three oral antiviral treatments for COVID-19 and 15 COVID-19 technologies. MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC). MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation and SDC. More information at https://medicinespatentpool.org/ and follow us on Twitter, LinkedIn and YouTube.

Founded in 2006, Meril is a global medical device company located in India, Meril was launched in line with the health-care diversification plan for global healthcare. Today, Meril is a global medical device company (distributing in over 120 countries) dedicated to the design and development of novel clinically relevant, state-of-the-art and best-in-class devices to alleviate human suffering and improve quality of life. We span a broad operational canvas ranging from Vascular Interventions, Orthopedics, Robotics, Endo-Surgery, In-vitro-Diagnostics & ENT.

We have RDTs in our product portfolio which are WHO PQ including HIV RDT, Malaria Pf/Pan RDT & Malaria Pf/Pv RDT. Also, we have COVID-19 rapid antigen as well as antibody tests with CE approval in place.

Headquartered in India with a manpower of more than 7000, Meril currently conducts business in more than 120 countries. We have 100% subsidiaries in more the 22 countries including the USA, Germany, Brazil, Russia, South Africa, Bangladesh, Malaysia and Turkey.

Download complete profile

Molbio Diagnostics, an innovative Indian In-Vitro Diagnostics (IVD) company, aims to decentralize and democratize access to high quality, affordable diagnostics across the world through novel, near patient and point-of-care solutions. Molbio's widely acclaimed Truenat® - a point-of-care Real Time PCR system, is the first such platform to be commercialized that has enabled even highly resource limited settings such as Primary and Community Health Centers to conduct sophisticated molecular diagnostics as the frontline tool for multiple diseases.

Truenat® has brought in a paradigm shift to disease control and management and created a huge impact on patient and societal well-being. Over the years, Truenat® has proven the ability to work at all levels of the healthcare sectors and has been established as a trusted brand that is creating impact cross the globe. Today, Molbio with a staff strength of about 700, is already the largest IVD company in India with over 6000+ installations in the public and private sector. Globally, with an installation base of around 1000 systems, the distribution of Truenat® is spread across 77+ countries.

Molbio aims to be a leading global player in the point of care diagnostics segment, continuing to innovate and bring new technologies for social betterment. Lets bring the lab to the people rather than people to the lab.

For more than 35 years, MSD has been committed to scientific research and discovery (R&D) in HIV. Today, we are developing a series of antiviral options designed to help people manage HIV and protect people from HIV, with the goal of reducing the growing burden of infection worldwide. We remain committed to working hand-in-hand with our partners in the global HIV community to address the complex challenges that impede progress toward ending the epidemic. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

National AIDS Council is a parastatal under the Ministry of Health and Child Care established through the Act of Parliament, National AIDS Council Act Chapter 15:14 of 1999. The Act mandates NAC to provide for measures to combat the spread of the Human Immuno Deficiency Virus & mitigate the impact of the Acquired Immune Deficiency Syndrome & the promotion, coordination and implementation of programmes. It is also mandated to administer the National AIDS Trust Fund (NATF) collected through the AIDS Levy. The organization has a vision of having a Zimbabwe free from HIV infections, stigma & AIDS related deaths by 2030.

Pharm Access Africa Limited (PAAL) is dedicated to transforming access to quality healthcare through innovation and strategic global partnerships. We bridge the gap between public, private and the NGO/FBO sectors, by tackling supply chain complexities, ensuring healthcare commodity availability, and creating a collaborative ecosystem that fuels sustainable health solutions. Our approach unites everyone on principles of humanity, at all levels, focusing on key areas like Essential Medicines (EM), HIV/AIDS, Non-Communicable Diseases (NCD), and Sexual & Reproductive Health (SRH) among others. We ensure that our partnerships remain impactful and fully embody our vision: "Better Health, Better Lives." Join us in building better health for tomorrow.

Organization for Public Health Interventions and Development (OPHID) is a Zimbabwean organization that develops and implements innovative approaches and strategies to strengthen the provision of quality HIV prevention, care and treatment services. We collaborate closely with the Ministry of Health and Child Care and have partnerships with local and regional organizations and research institutions to ensure Zimbabweans have enhanced access to quality HIV, Tuberculosis, Prevention of Mother-To-Child Transmission of HIV, Sexual Reproductive Health and Maternal, Neonatal and Child Health services. Currently we implement the Target Accelerate Sustain Quality Care program, a PEPFAR-supported 5-year grant supporting 333,620 PLHIV on antiretroviral therapy.

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics.

The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions.

OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.

Paediatric - Adolescent & Treatment Africa (PATA) is PATA is an action network of frontline healthcare providers, who work in partnership with communities providing access to HIV prevention services, treatment, and comprehensive people-centred care; that is rights-based, friendly and stigma free. Our goal is to effect positive change in paediatric and adolescent HIV policy and service delivery on the frontline.

PATA does this by facilitating a powerful platform and processes for regional collaboration, capacity building, peer-to-peer exchange and learning, and advocacy for practice, programme and policy improvements in the HIV response.

Premier Medical Corporation Private Limited is a private manufacturer of medical diagnostic products and a marketing company founded in New Jersey in 1996. Premier Medical Corporation Private Limited was incorporated as a Delaware Corporation in March 1996. The company developed a strategic alliance with several diagnostic companies to develop, manufacture, and market a wide range of rapid diagnostic products in India and other developing countries. The company selected India as its worldwide transnational operational site to transfer critical technologies and provide its services to customers in India and developing markets. The company has obtained the necessary government approvals to manufacture and market its products. The company has agreements with different distributors for the distribution of manufactured diagnostic kits in various countries.

In March 1997, the company established its manufacturing facility in Daman, India, equipped with a modern Quality Testing Laboratory. Daman is a Union Territory located on the West Coast of India, just 120 miles north of Mumbai. Since 1997, Premier Medical Corporation Private Limited has initiated the development of an integrated manufacturing, marketing, and distribution operation under the brand names Sure Status®, First Response®, and AQ Check®. The company has established a robust distribution network throughout India and has formed strategic co-marketing alliances with leading biotech companies. The company currently serves diverse customer groups in India, including healthcare professionals such as physicians, laboratories, hospitals, government health centers, distributors, and retailers. The organization changed its name from PMC Medical (India) Private Limited to Premier Medical Corporation Limited in 2007. The second production unit was established under the name of Premier Medical Corporation Limited in Sarigam, Gujarat, India in 2012. The organization changed its name again from Premier Medical Corporation Limited to Premier Medical Corporation Private Limited in 2015, and the organization complies with Quality Management Systems (ISO 13485, WHO requirements, Directive 98/79/EC, MDR 2017 India, and applicable regulations).

The company has entered into strategic alliances with advanced medical diagnostic and device developing companies to develop manufacture and market products throughout the world. The medical diagnostic tests are both qualitative and semi-quantitative, designed to detect infectious diseases. The company's performance is the result of dynamic leadership by the company's promoter, Mr. Neil Mehta, a technocrat, backed by highly qualified, skilled, and dedicated personnel.

PMC was founded with a strategic vision: Premier Medical Corporation Private Limited aims to become a leader in the global healthcare industry by providing innovative, user-friendly, reliable, safe, and affordable in vitro diagnostic products for the benefit of patients' lives and overall public health.

Population Solutions for Health (PSH) is a locally registered trust with a 23-year track record of supporting the Zimbabwean Ministry of Health and Child Care (MoHCC) in implementing high-impact HIV and Sexual and Reproductive Health Rights (SRHR) programs. PSH is a leader in community-based and differentiated HIV service delivery, serving AGYW, men and boys, and Key Populations. PSH’s HIV programming spans the clinical cascade including social marketing of male condoms; Voluntary Medical Male Circumcision; HIV Testing (focusing on case finding and HIVST); community-based HIV treatment; STI management, PrEP and post-exposure prophylaxis (PEP).

SAYWHAT (Students and Youth Working on reproductive Health Action Team) is a Southern African public health advocacy institution established in 2003. SAYWHAT focuses on promoting young people's access to health and education rights, services, and commodities. SAYWHAT operates through student structures in over 30 tertiary institutions in Zimbabwe and coordinates regional influence through the Southern African Regional Students and Youth Consortium on sexual and reproductive health (SARSYC). The organization engages in capacity building, research, documentation, advocacy, and child protection initiatives. SAYWHAT's Studio of Choice nurtures artistic talents and produces initiatives such as debate competitions, quiz challenges, and the CONDOMIZE campaign. The organization aims to become a pan-African organization with continental coverage by 2050.

SD Biosensor, Inc., with its slogan ‘Beginning of all things that protect lives,’ is a global in-vitro diagnostics company that contributes to improving everyone’s quality of life by diagnosing diseases quickly and accurately. SD Biosensor is a Total Solution Provider in the IVD industry that develops and researches innovative diagnostic platforms. In 2020, SD Biosensor, Inc. began supplying numerous WHO prequalified for global public health diagnostic products, especially those for malaria, HIV, HCV, and COVID-19. SD Biosensor, Inc. will continue to grow as a global biotech company by creating new value through accumulating data using AI as well as in the areas of diagnosis, products, and services..

The Society for AIDS in Africa (SAA) was established in Kinshasa in October 1990 during the 5th International Conference on AIDS and Associated Cancers in Africa, a precursor to the International Conference on AIDS and STIs in Africa (ICASA).

The formation of SAA with the support of the World Health Organization (WHO) brought to an end, the practice of organizing the International Conference on AIDS in Africa, outside the African continent. At the same time, it empowered Africans to address and respond to the challenges posed by HIV/AIDS on the continent.

The SAA envisions an HIV free Africa with capacity to confront HIV/AIDS and its consequences as well as its related diseases (such as Tuberculosis and Malaria).

The Society also promotes positive environment and research on HIV and its related diseases. The SAA is governed by an Executive Council drawn from South, North, East, West and Central Africa.

SAA partners and collaborates with range of NGOs and it enjoys the support of the UN-System, as well as various International organizations, including the International AIDS Society (IAS). The Society for AIDS in Africa, is the organizer of ICASA. The next ICASA will be organized in 2023. The host country will be announced soon.

Satewave Technologies was founded in 2008 as a comprensive solution provider , mainly engaged in health sector ,IT sector,telecommunications , smart city , internet of things ,photovaitic sector, products and services. Our main customers are government departments and state owned enterprises for example ministry of health providing health equipment and medicals and private organisations. With the core values of innovation, customer orientation and excellent quality, we are committed to provide efficient customized solutions and establishing long term partnership with customers, through our skilled team members.

The Global Fund is a partnership to defeat HIV, TB and malaria and ensure a healthier, safer, more equitable future for all.

We raise and invest US$4billion a year to fight the deadliest infectious diseases, challenge the inequity which fuels them and strengthen health systems in more than 100 countries.

We unite world leaders, communities, civil society, health workers and the private sector to find out what works and take it to scale – so the world makes more progress, more rapidly.

It’s working. Since 2002, we have saved 50 million lives. We won’t stop until the job is finished.

Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global teams delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. We are truly global with >125,000 employees worldwide (including 5,700 scientists). Across the African continent, we have scaled up our business operations across our distributor networks, partner organizations, and sales and technical services support.

UNAIDS leads the global effort to end AIDS as a public health threat by 2030 as part of the United Nations Sustainable Development Goals.

It provides the strategic direction, advocacy, coordination and technical support to catalyse and connect governments, the private sector and communities to deliver life-saving HIV services. UNAIDS provides the most extensive data collection on HIV epidemiology, programme coverage and finance and publishes the most authoritative and up-to-date information on the epidemic—vital for an effective HIV response.

UNAIDS draws on the experience and expertise of 11 United Nations system cosponsors, with civil society represented on its governing body.

UNICEF works in the world’s toughest places to reach the most disadvantaged children and adolescents – and to protect the rights of every child, everywhere. Across more than 190 countries and territories, UNICEF does whatever it takes to help children survive, thrive and fulfil their potential, from early childhood through adolescence. Before, during and after humanitarian emergencies, UNICEF is on the ground, bringing lifesaving help and hope to children and families. Non-political and impartial, UNICEF is never neutral when it comes to defending children’s rights and safeguarding their lives and futures.

UNFPA is the United Nations sexual and reproductive health agency. Our mission is to deliver a world where every pregnancy is wanted, every childbirth is safe and every young person's potential is fulfilled. We promote gender equality and empower women, girls and young people to take control of their bodies and their futures. We work with partners in more than 150 countries to provide access to a wide range of sexual and reproductive health services. Our goal is ending unmet need for family planning, preventable maternal death, and gender-based violence and harmful practices including child marriage and female genital mutilation by 2030.

ViiV Healthcare is a global specialist pharmaceutical company 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS. Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, at ViiV Healthcare we are determined to help end the HIV epidemic. From our unique origins to our innovative medicines, we push the boundaries of what people think is possible in HIV treatment and care. Our one focused goal unites our employees located across the globe, with their expertise in research, manufacturing, policy and more, all guided by our mission to be here until HIV isn’t.

Visit www.viivhealthcare.com to find out more about who we are, what we do and how we do it.

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. Find out more at Viatris.com

The WHO Regional Office for Africa (WHO/AFR) is one of WHO’s six regional offices around the world. It serves the WHO African Region, covering 47 countries comprising all sub-Sahara African countries and Algeria. Dedicated to the well-being of people and guided by science, the World Health Organization leads and champions efforts to give everyone in the region, an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners, and people across the region, leading the response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. More at www.afro.who.int